Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal
Go back to Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal| Pfizer Inc. (NYSE: PFE) | Delayed: 28.55 +0.09 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.46 | 52 Week High | $37.39 | |||
| Open | $28.82 | 52 Week Low | $28.25 | |||
| Day High | $29.09 | P/E | 17.30 | |||
| Day Low | $28.47 | EPS | $1.65 | |||
| Volume | 42,562,125 | |||||
| Sangamo Biosciences, Inc. (NASDAQ: SGMO) | Delayed: 0.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $9.91 | |||
| Open | $0.18 | 52 Week Low | $3.10 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $-0.48 | |||
| Volume | 200 | |||||
